Skip to content

A prospective study to evaluate the efficacy and safety of a new knife in endoscopic treatment for gastric neoplasm

A prospective study to evaluate the efficacy and safety of a new knife in endoscopic submucosal dissection for gastric neoplasm

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0005164
Enrollment
100
Registered
2020-06-24
Start date
2020-08-27
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Subjects are randomized to the experimental group (H knife) or control group (IT knife). Each procedure between the groups is the same except knife.

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. 19 years old or older 2. Diagnosed as adenoma or early gastric cancer and meets the indications for endoscopic resection 3. Where he/she voluntarily signed a written informed consent form after hearing an explanation of the purpose, method, effect, etc. of the study

Exclusion criteria

Exclusion criteria: 1. Women of childbearing potential who are unable to use adequate contraception or are pregnant or lactating 2. Past history of gastrectomy 3. When endoscopic resection cannot be safely performed due to hemorrhagic disease or coagulation disorder 4. When the investigator determines that endoscopic resection is impossible

Design outcomes

Primary

MeasureTime frame
Time differences for endoscopic resection

Secondary

MeasureTime frame
Time of marking around the lesion;Number of accessories;Complete resection rate

Countries

Korea, Republic of

Contacts

Public ContactDo Hoon Kim

Asan Medical Center

dohoon.md@gmail.com+82-2-3010-3193

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Apr 4, 2026